MedTrace Logo

Cervical Cancer Susceptible Population Classification

NCT06405945 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2024-05-09

No results posted yet for this study

Summary

Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervical cancer. However, many reports lack clarity, consistency, and validation. In this comprehensive study, we will analyze the genomic risk factors associated with cervical cancer, classify individuals into different risk categories, and explore potential biomarkers and therapeutics.

Conditions

  • Cervical Cancer Susceptible Population Classification

Interventions

GENETIC

PCR and sequence

sequence the mutatation SNPs

Sponsors & Collaborators

  • Anhui Provincial Hospital

    lead OTHER_GOV

Principal Investigators

  • Yingying Wang, Doctor · The First Affiliated Hospital of USTC

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2034-04-30
Completion
2036-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06405945 on ClinicalTrials.gov